Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,514
Closed -$40K – 1852
2026
Q2
$40K Hold
6,514
– – ﹤0.01% 1769
2026
Q1
$34K Hold
6,514
– – ﹤0.01% 1763
2025
Q4
$48K Hold
6,514
– – ﹤0.01% 1647
2025
Q3
$65K Hold
6,514
– – ﹤0.01% 1534
2025
Q2
$59K Sell
6,514
-5,009
-43% -$32.7K ﹤0.01% 1521
2025
Q1
$74K Buy
11,523
+1,078
+10% +$9.6K ﹤0.01% 1642
2024
Q4
$99K Buy
10,445
+4,800
+85% +$42.1K ﹤0.01% 1551
2024
Q3
$46K Hold
5,645
– – ﹤0.01% 1745
2024
Q2
$76K Hold
5,645
– – ﹤0.01% 1345
2024
Q1
$40K Buy
5,645
+2,330
+70% +$20.2K ﹤0.01% 1669
2023
Q4
$36K Hold
3,315
– – ﹤0.01% 1720
2023
Q3
$36K Buy
+3,315
New +$47.4K ﹤0.01% 1684

Other funds holding ENVX

KBC Group's ENVX Position: Q3 2026 in Review

KBC Group sold out of Enovix (ENVX) in Q3 2026, closing a stake of 6,514 shares — an estimated $40K sold.

KBC Group first reported a position in ENVX in Q3 2023 and held it in 12 quarters. The position peaked at $99K in Q4 2024. 65 funds tracked by Wall St. Rank hold ENVX as of Q3 2026.

  • KBC Group reported no remaining Enovix position as of Q3 2026 after selling out during the quarter.
  • KBC Group sold 6,514 Enovix shares in Q3 2026, an estimated $40K.
  • KBC Group first reported a position in Enovix in Q3 2023 and held it in 12 quarters.
  • KBC Group's Enovix position peaked at $99K in Q4 2024.
  • 65 funds tracked by Wall St. Rank held Enovix as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.